Long Term Documentation of the Safety and Efficacy as Well as the Effects on Quality of Life and Work Productivity in Patients With Rheumatoid Arthritis Under HUMIRA® (Adalimumab) in Routine Clinical Practice (AGIL)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 7,229
- 主要终点
- Change From Baseline in Number of Missed Working Days Due to Sick Leave in the Past 6 Months
研究概览
简要总结
The AGIL study was designed to evaluate the effectiveness and safety of adalimumab over 5 years in routine daily clinical practice in Germany, with a focus on the impact of therapy on employment-related outcomes.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 99 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Moderate to severe active rheumatoid arthritis in adults with insufficient response to disease-modifying antirheumatic drugs
- •Inclusive methotrexate
- •Moderate to severe active rheumatoid arthritis in adults who have not been treated with methotrexate before; In case of incompatibility with methotrexate, Humira can be used as monotherapy.
排除标准
- •Hypersensitivity against the drug or one of the other ingredients
- •Active tuberculosis or other severe infections (e.g. sepsis and opportunistic infections)
- •Moderate to severe cardiac insufficiency
结局指标
主要结局
Change From Baseline in Number of Missed Working Days Due to Sick Leave in the Past 6 Months
时间窗: Baseline and 6, 12, 24, 36, 48, and 60 months
Primary effectiveness outcomes related to employment were performed in patients who were employed part- or full-time at baseline. Sick leave days were based on patient recall.
Percentage of Participants With > 5 Missed Working Days Due to Sick Leave in the Past 6 Months
时间窗: Baseline, 6, 12, 24, 36, 48, and 60 months
Primary effectiveness outcomes related to employment were performed in patients who were employed part- or full-time at baseline. Sick leave days were based on patient recall.
Change From Baseline in Work Productivity and Activity Impairment: Absenteeism
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The Work Productivity and Activity Impairment (WPAI) questionnaire for general health is a validated tool in RA consisting of 6 questions, based on patient recall of the previous 7 days. WPAI assesses work time missed due to illness (absenteeism), impairment at work due to health (presenteeism), total work productivity impairment due to health (an aggregate measure of both absenteeism and presenteeism), and total non-occupational activity impairment due to health. WPAI scores are expressed as impairment percentages, with higher scores indicating worse outcomes.
Change From Baseline in Work Productivity and Activity Impairment: Presenteeism
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The Work Productivity and Activity Impairment (WPAI) questionnaire for general health is a validated tool in RA consisting of 6 questions, based on patient recall of the previous 7 days. WPAI assesses work time missed due to illness (absenteeism), impairment at work due to health (presenteeism), total work productivity impairment due to health (an aggregate measure of both absenteeism and presenteeism), and total non-occupational activity impairment due to health. WPAI scores are expressed as impairment percentages, with higher scores indicating worse outcomes.
Change From Baseline in Work Productivity and Activity Impairment: Total Work Productivity Impairment
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The Work Productivity and Activity Impairment (WPAI) questionnaire for general health is a validated tool in RA consisting of 6 questions, based on patient recall of the previous 7 days. WPAI assesses work time missed due to illness (absenteeism), impairment at work due to health (presenteeism), total work productivity impairment due to health (an aggregate measure of both absenteeism and presenteeism), and total non-occupational activity impairment due to health. WPAI scores are expressed as impairment percentages, with higher scores indicating worse outcomes.
Change From Baseline in Disease Activity Score - 28 Joints (DAS28)
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, erythrocyte sedimentation rate (ESR), and the patient's assessment of global disease activity are included in the DAS28 score. Scores on the DAS28 range from 0 to 10. A DAS28 score \> 5.1 indicates high disease activity, a DAS28 score \< 3.2 indicates low disease activity, and a DAS28 score \< 2.6 indicates clinical remission.
Change From Baseline in Work Productivity and Activity Impairment: Total Activity Impairment
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The Work Productivity and Activity Impairment (WPAI) questionnaire for general health is a validated tool in RA consisting of 6 questions, based on patient recall of the previous 7 days. WPAI assesses work time missed due to illness (absenteeism), impairment at work due to health (presenteeism), total work productivity impairment due to health (an aggregate measure of both absenteeism and presenteeism), and total non-occupational activity impairment due to health. WPAI scores are expressed as impairment percentages, with higher scores indicating worse outcomes.
Change From Baseline in Work Activity Index (WAI)
时间窗: Baseline and 6, 12, 24, 36, 48, and 60 months
The WAI is a tool designed to record the work ability of employees and consists of 7 questions. The modified WAI used in this study included Questions 1, 2, 4, 6, and 7 of the WAI. Question 3, which involves the number of current diseases diagnosed by a physician, was omitted because this parameter was unlikely to reflect change due to treatment. Question 5 (sick leave during the past year) was replaced with the previous question concerning sick leave days.WAI scores range from 7 (worst) to 49 (best).
Change From Baseline in Tender Joint Count
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
Twenty-eight joints were assessed and classified as tender/not tender by pressure and joint manipulation on physical examination.
Change From Baseline in Swollen Joint Count
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
Twenty-eight joints were assessed and classified as swollen/not swollen by pressure and joint manipulation on physical examination.
Change From Baseline in Erythrocyte Sedimentation Rate
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
Change From Baseline in C-reactive Protein
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
Change From Baseline in Health-Assessment Questionnaire-Disability Index (HAQ-DI)
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The HAQ-DI is a patient-reported assessment of physical function that includes 20 items in eight categories representing a comprehensive set of functional activities, including dressing, eating, walking, and hygiene. Patients are asked about their ability to complete these tasks in the past week using the following categories: without any difficulty (0); with some difficulty (1); with much difficulty (2); and unable to do (3). Scores on each task were summed and averaged to provide an overall score ranging from 0 (best) to 3 (worst), with a higher score representing a high-dependency disability.
EuroQol-5 Dimensions (EQ-5D) Scores
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
The EuroQol-5 Dimensions (EQ-5D) is a generic instrument for measuring health-related quality of life. The patient questionnaire consists of two parts. The first part includes statements for the following five areas (dimensions): * agility/mobility * self-care * usual activities * pain, bodily discomfort * anxiety, depression For each dimension the patient is asked for a three-level assessment of their health on the current day: "no problems" (1), "some problems" (2), "extreme problems" (3).
Change From Baseline in Euroqol Visual Analog Scale (VAS)
时间窗: Baseline and 3, 6, 12, 24, 36, 48, and 60 months
EuroQol-5 Dimensions (EQ-5D): The EQ-5D is a generic instrument for measuring health-related quality of life. The patient questionnaire consists of two parts. The second part is a vertical, thermometer-like, VAS ranging from 0 to 100 that provides a patient-reported assessment of overall health. Patients are asked to mark how good or bad their health is on that day, with 100 meaning "the best health you can imagine" and 0 meaning "the worst health you can imagine."
次要结局
- Number of Physician Visits in Past 6 Months(Baseline, 6, 12, 24, 36, 48, and 60 months)
- Number of Inpatient Hospitalizations in Past 6 Months(Baseline, 6, 12, 24, 36, 48, and 60 months)
- Duration of Inpatient Hospitalizations in Past 6 Months(Baseline, 6, 12, 24, 36, 48, and 60 months)
- Number of Days With Impairment of Non-Occupational Activities in Past 6 Months(Baseline, 6, 12, 24, 36, 48, and 60 months)
- Duration of Morning Stiffness(Baseline and 3, 6, 12, 24, 36, 48, and 60 months)
- Participant's Assessment of Pain(Baseline and 3, 6, 12, 24, 36, 48, and 60 months)
- Participant's Assessment of Fatigue(Baseline and 3, 6, 12, 24, 36, 48, and 60 months)
- Percentage of Participants Taking Concomitant RA Medications(Baseline to month 60)
- Patient Assessment of Adalimumab Therapy(Months 3, 6, 12, 24, 36, 48, and 60)
